LivaNova (LIVN) EPS (Basic) Growth (3y) (2017 - 2026)
LivaNova (LIVN) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 17.98% |
| 10 | LivaNova | 4.31 Bn | 3.79 Bn | 273.67 Mn | 348.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 348.01% |
| Mar 31, 2026 | 45.30% |
| Dec 31, 2025 | 161.75% |
| Sep 30, 2025 | 30.93% |
| Jun 30, 2025 | 17.34% |
| Mar 31, 2025 | -375.82% |
| Dec 31, 2023 | 216.11% |
| Mar 31, 2023 | 105.85% |
| Dec 31, 2022 | 101.42% |
| Jun 30, 2022 | 337.39% |
| Dec 31, 2020 | 81.68% |
| Mar 31, 2020 | 20.40% |
| Dec 31, 2019 | 26.16% |
| Jun 30, 2019 | 26.99% |
| Dec 31, 2018 | 64.08% |
| Dec 31, 2017 | -131.07% |